Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alphatec Holdings, Inc. | EVP, CLINICAL STRATEGIES | Common Stock | 540K | $8.1M | $15.00 | Aug 5, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATEC | Alphatec Holdings, Inc. | Aug 5, 2022 | 1 | -$48.6K | 4 | Aug 9, 2022 | EVP, CLINICAL STRATEGIES |
ATEC | Alphatec Holdings, Inc. | Mar 18, 2022 | 1 | -$32.2K | 4 | Mar 22, 2022 | EVP, Clinical Strategies |
ATEC | Alphatec Holdings, Inc. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | EVP, Clinical Strategies |
ATEC | Alphatec Holdings, Inc. | Aug 5, 2021 | 1 | -$92.1K | 4 | Aug 9, 2021 | EVP, Clinical Strategies |
ATEC | Alphatec Holdings, Inc. | May 17, 2021 | 1 | -$260K | 4 | May 19, 2021 | EVP, Clinical Strategies |